CA2001996A1 - Methode de traitement de la cystite interstitielle - Google Patents
Methode de traitement de la cystite interstitielleInfo
- Publication number
- CA2001996A1 CA2001996A1 CA2001996A CA2001996A CA2001996A1 CA 2001996 A1 CA2001996 A1 CA 2001996A1 CA 2001996 A CA2001996 A CA 2001996A CA 2001996 A CA2001996 A CA 2001996A CA 2001996 A1 CA2001996 A1 CA 2001996A1
- Authority
- CA
- Canada
- Prior art keywords
- interstitial cystitis
- treatment
- naltrexone
- nalmefene
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005615 Interstitial Cystitis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 2
- 229960005297 nalmefene Drugs 0.000 abstract 2
- 229960003086 naltrexone Drugs 0.000 abstract 2
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 abstract 2
- 239000003887 narcotic antagonist Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Threshing Machine Elements (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US265,575 | 1988-11-01 | ||
| US07/265,575 US4877791A (en) | 1988-11-01 | 1988-11-01 | Method of treatment for interestitial cystitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2001996A1 true CA2001996A1 (fr) | 1990-05-01 |
| CA2001996C CA2001996C (fr) | 1996-07-23 |
Family
ID=23011021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002001996A Expired - Fee Related CA2001996C (fr) | 1988-11-01 | 1989-11-01 | Methode de traitement de la cystite interstitielle |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4877791A (fr) |
| EP (1) | EP0367533B1 (fr) |
| JP (1) | JPH07556B2 (fr) |
| AT (1) | ATE102830T1 (fr) |
| AU (1) | AU623189B2 (fr) |
| CA (1) | CA2001996C (fr) |
| DE (1) | DE68913907T2 (fr) |
| DK (1) | DK541189A (fr) |
| HK (1) | HK119994A (fr) |
| NO (1) | NO894295L (fr) |
| ZA (1) | ZA897823B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
| US4994466A (en) * | 1990-06-14 | 1991-02-19 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for multiple sclerosis |
| US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
| US5145859A (en) * | 1991-03-20 | 1992-09-08 | Case Western Reserve University | Methods of treating interstitial cystitis and urethral syndrome |
| ES2214532T3 (es) | 1995-03-03 | 2004-09-16 | Endo Pharmaceuticals Inc. | Uso de dextrorfano o dextrometorfano para el tratamiento de la incontinencia urinaria. |
| US5878750A (en) * | 1996-11-14 | 1999-03-09 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
| US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
| WO2000044390A1 (fr) * | 1999-02-01 | 2000-08-03 | John Lezdey | Traitement de la mastocytose gastro-intestinale et de la vessie |
| US6528520B2 (en) * | 2000-08-15 | 2003-03-04 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
| US6262062B1 (en) | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
| US6846831B2 (en) | 2000-08-15 | 2005-01-25 | Cpd, Llc | Method of treating the syndrome of lipodystrophy |
| WO2002081477A1 (fr) * | 2001-03-30 | 2002-10-17 | Toray Industries, Inc. | Derives morphinane 7-substitues et leur utilisation medicinale |
| US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
| US8017622B2 (en) * | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| NZ571537A (en) * | 2006-04-03 | 2012-06-29 | Nutramax Lab Inc | Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them |
| EP2365759B1 (fr) * | 2008-12-16 | 2018-03-07 | Hill's Pet Nutrition, Inc. | Composition alimentaire contenant un anti-oxydant contribuant à inhiber les voies de libération de l'histamine chez les animaux de compagnie |
| WO2019227053A1 (fr) * | 2018-05-25 | 2019-11-28 | Adamis Pharmaceuticals Corporation | Compositions de médicament |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU538186B2 (en) * | 1980-03-07 | 1984-08-02 | Scotia Holdings Plc | Prostaglandin precursors |
| JPS63501717A (ja) * | 1985-10-29 | 1988-07-14 | ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド | 抗原誘発性アレルギ−反応を阻止するための方法および組成物 |
| FR2609632B1 (fr) * | 1987-01-21 | 1991-03-29 | Shelly Marc | Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage |
| US4880813A (en) * | 1988-07-22 | 1989-11-14 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for allergic rhinitis |
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
-
1988
- 1988-11-01 US US07/265,575 patent/US4877791A/en not_active Expired - Fee Related
-
1989
- 1989-10-16 ZA ZA897823A patent/ZA897823B/xx unknown
- 1989-10-25 JP JP1279638A patent/JPH07556B2/ja not_active Expired - Lifetime
- 1989-10-27 NO NO89894295A patent/NO894295L/no unknown
- 1989-10-27 AU AU43850/89A patent/AU623189B2/en not_active Ceased
- 1989-10-30 DK DK541189A patent/DK541189A/da not_active Application Discontinuation
- 1989-10-30 EP EP89311177A patent/EP0367533B1/fr not_active Expired - Lifetime
- 1989-10-30 AT AT89311177T patent/ATE102830T1/de not_active IP Right Cessation
- 1989-10-30 DE DE68913907T patent/DE68913907T2/de not_active Expired - Fee Related
- 1989-11-01 CA CA002001996A patent/CA2001996C/fr not_active Expired - Fee Related
-
1994
- 1994-11-03 HK HK119994A patent/HK119994A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK119994A (en) | 1994-11-11 |
| DK541189A (da) | 1990-05-02 |
| JPH02188525A (ja) | 1990-07-24 |
| EP0367533A3 (fr) | 1991-10-02 |
| NO894295L (no) | 1990-05-02 |
| AU623189B2 (en) | 1992-05-07 |
| CA2001996C (fr) | 1996-07-23 |
| DE68913907T2 (de) | 1994-06-23 |
| JPH07556B2 (ja) | 1995-01-11 |
| DE68913907D1 (de) | 1994-04-21 |
| ATE102830T1 (de) | 1994-04-15 |
| EP0367533B1 (fr) | 1994-03-16 |
| DK541189D0 (da) | 1989-10-30 |
| AU4385089A (en) | 1990-05-10 |
| NO894295D0 (no) | 1989-10-27 |
| EP0367533A2 (fr) | 1990-05-09 |
| ZA897823B (en) | 1990-07-25 |
| US4877791A (en) | 1989-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3827989A (en) | Method of treatment for autoimmune diseases | |
| AU623189B2 (en) | Method of treatment for interstitial cystitis | |
| EP0377272A3 (fr) | Utilisation de nalméfène ou naltrexone pour l'obtention d'un médicament destiné au traitement de l'inflammation dans l'arthrite ou dans des maladies inflammatoires associées | |
| EP0449247A3 (en) | Pharmaceutical composition containing galanthamine for treating alcoholism | |
| GEP20032965B (en) | Pharmaceutical Compound | |
| CA2114014A1 (fr) | Systeme d'administration de medicament et methode pour traiter a l'aide de la carbamazepine les troubles psychiatriques, neurologiques et autres | |
| GB8712073D0 (en) | Medicament | |
| GB9519661D0 (en) | Fatty acid treatment | |
| AU1189688A (en) | Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states | |
| AU7807791A (en) | Method of treating impotence | |
| GR3034186T3 (en) | 3,4-diarylchromans for treatment of dermatitis | |
| AU1117092A (en) | Treatment of lower urinary tract disorders | |
| ATE78687T1 (de) | Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen. | |
| EP0319962A3 (fr) | Dérivés de la pipéridinyl méthanol pour le traitement de l'anxiété | |
| DK0583026T3 (fr) | ||
| EP0362847A3 (fr) | Emploi de l'étopéritone pour obtenir une composition pharmaceutique pour le traitement de l'impotence chez l'homme | |
| GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
| AU8166291A (en) | Method of treating mast cell disease | |
| AU2908389A (en) | Device for administering medicaments by atomization in intubated or tracheotomized patients | |
| HU906436D0 (en) | Process for the production of 3-substituted 2-oxyndole-derivatives | |
| GR3015107T3 (en) | Use of zofenopril for the preparation of drugs against rheumatoid arthritis. | |
| ZA927362B (en) | Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |